Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer
Sonam Roy, Taj Mohammad, Preeti Gupta, et al.
ACS Omega (2020) Vol. 5, Iss. 34, pp. 21550-21560
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

A comprehensive overview of β-carbolines and its derivatives as anticancer agents
Bo Luo, Xinqiang Song
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113688-113688
Closed Access | Times Cited: 55
Antiviral activities of plant-derived indole and β-carboline alkaloids against human and avian influenza viruses
Akram Hegazy, Sara H. Mahmoud, Yaseen A. M. M. Elshaier, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Herbal compounds as promising therapeutic agents in precision medicine strategies for cancer: A systematic review
Bizhar Ahmed Tayeb, Ikhwan Yuda Kusuma, Alaa A. Osman, et al.
Journal of Integrative Medicine (2024) Vol. 22, Iss. 2, pp. 137-162
Closed Access | Times Cited: 10
Exploring MTH1 inhibitory potential of Thymoquinone and Baicalin for therapeutic targeting of breast cancer
Aaliya Taiyab, Arunabh Choudhury, Shaista Haidar, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116332-116332
Open Access | Times Cited: 10
Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy
Mohd Yousuf, Parvez Κhan, Anas Shamsi, et al.
ACS Omega (2020) Vol. 5, Iss. 42, pp. 27480-27491
Open Access | Times Cited: 66
Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases
Yanhong Bu, Hong Wu, Ran Deng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 41
Investigating neuroprotective roles of Bacopa monnieri extracts: Mechanistic insights and therapeutic implications
Urooj Fatima, Sonam Roy, Shahnawaz Ahmad, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113469-113469
Closed Access | Times Cited: 34
Therapeutic implications and clinical manifestations of thymoquinone
Manzar Alam, Gulam Mustafa Hasan, Md. Meraj Ansari, et al.
Phytochemistry (2022) Vol. 200, pp. 113213-113213
Closed Access | Times Cited: 30
Pharmacological features, health benefits and clinical implications of honokiol
Fatima Khatoon, Sabeeha Ali, Vijay Kumar, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 15, pp. 7511-7533
Closed Access | Times Cited: 28
Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment
Morena Miciaccia, Francesca Rizzo, Antonella Centonze, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 135-135
Open Access | Times Cited: 5
Targeting prostate cancer via therapeutic targeting of PIM-1 kinase by Naringenin and Quercetin
Aanchal Rathi, Arunabh Chaudhury, Farah Anjum, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 133882-133882
Closed Access | Times Cited: 5
Synthesis of harmaline N-9 derivatives and investigation of in vitro anticancer activity
Yongjian Liu, Hao Liu, Shuqi Li, et al.
Bioorganic & Medicinal Chemistry Letters (2025) Vol. 119, pp. 130106-130106
Closed Access
Identification of plant-based hexokinase 2 inhibitors: combined molecular docking and dynamics simulation studies
Asifa Khan, Taj Mohammad, Anas Shamsi, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 20, pp. 10319-10331
Closed Access | Times Cited: 36
Thymoquinone and quercetin induce enhanced apoptosis in non‐small cell lung cancer in combination through the Bax/Bcl2 cascade
Shoaib Alam, Taj Mohammad, Rayees Ahmad Padder, et al.
Journal of Cellular Biochemistry (2021) Vol. 123, Iss. 2, pp. 259-274
Closed Access | Times Cited: 31
Investigating binding mechanism of thymoquinone to human transferrin, targeting Alzheimer's disease therapy
Bin Xue, Debarati DasGupta, Manzar Alam, et al.
Journal of Cellular Biochemistry (2022) Vol. 123, Iss. 8, pp. 1381-1393
Closed Access | Times Cited: 19
Harmaline exerts potentially anti-cancer effects on U-87 human malignant glioblastoma cells in vitro
Mohammad Mahdi Vahedi, Ali Shahini, Mehran Mottahedi, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 5, pp. 4357-4366
Closed Access | Times Cited: 9
Investigation of sphingosine kinase 1 inhibitory potential of cinchonine and colcemid targeting anticancer therapy
Sonam Roy, Shama Khan, Deeba Shamim Jairajpuri, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 14, pp. 6350-6362
Closed Access | Times Cited: 22
Harmaline induces apoptosis and inhibits migration in A2780 ovarian cancer cells in vitro
Seyed Ali Shariat Razavi, Masoumeh Taghdisi Khaboushan, Raha Jafari, et al.
Physiological Reports (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 2
Thymoquinone, artemisinin, and thymol attenuate proliferation of lung cancer cells as Sphingosine kinase 1 inhibitors
Ilma Shakeel, Shaista Haider, Shama Khan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117123-117123
Open Access | Times Cited: 2
FDA-approved drugs as PIM-1 kinase inhibitors: A drug repurposed approach for cancer therapy
Aanchal Rathi, Saba Noor, Md Nayab Sulaimani, et al.
International Journal of Biological Macromolecules (2024), pp. 139107-139107
Closed Access | Times Cited: 2
Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target
Mengmeng Lin, Yingying Li, Shiyuan Wang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 12
Anticancer Potential of β‐Carboline Alkaloids: An Updated Mechanistic Overview
Phumudzo P. Tshikhudo, Tafadzwanashe Mabhaudhi, Neil A. Koorbanally, et al.
Chemistry & Biodiversity (2023) Vol. 21, Iss. 2
Closed Access | Times Cited: 7
Harmaline downregulates angiogenesis markers and suppresses the growth of 4T1 breast cancer cells in vivo and in vitro
Mohsen Rashidi, Elham Mahmoudian, Sepideh Mirzaei, et al.
Chemico-Biological Interactions (2022) Vol. 365, pp. 110087-110087
Closed Access | Times Cited: 11
The folate-chitosan-decorated harmaline nanostructured lipid carrier (FCH-NLC), the efficient selective anticancer nano drug delivery system
Zahra Larian, Masoud Homayouni Tabrizi, Ehsan Karimi, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 88, pp. 104864-104864
Closed Access | Times Cited: 5
pro-apoptotic and anti-metastatic potentials of harmaline-silver containing folate-linked chitosan nano-drug delivery system.
Ali Hussein Wannas Al-Harmooshee, Masoud Homayouni Tabrizi, Nasim Hayati Roodbari
PubMed (2024) Vol. 27, Iss. 2, pp. 180-187
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top